203 related articles for article (PubMed ID: 31820265)
1. Diagnostic performance and inter-operator variability of apparent diffusion coefficient analysis for differentiating pleomorphic adenoma and carcinoma ex pleomorphic adenoma: comparing one-point measurement and whole-tumor measurement including radiomics approach.
Wada T; Yokota H; Horikoshi T; Starkey J; Hattori S; Hashiba J; Uno T
Jpn J Radiol; 2020 Mar; 38(3):207-214. PubMed ID: 31820265
[TBL] [Abstract][Full Text] [Related]
2. A triple-classification radiomics model for the differentiation of pleomorphic adenoma, Warthin tumour, and malignant salivary gland tumours on the basis of diffusion-weighted imaging.
Shao S; Zheng N; Mao N; Xue X; Cui J; Gao P; Wang B
Clin Radiol; 2021 Jun; 76(6):472.e11-472.e18. PubMed ID: 33752882
[TBL] [Abstract][Full Text] [Related]
3. The Difference in the Clinical Features Between Carcinoma ex Pleomorphic Adenoma and Pleomorphic Adenoma.
Seok J; Hyun SJ; Jeong WJ; Ahn SH; Kim H; Jung YH
Ear Nose Throat J; 2019 Sep; 98(8):504-509. PubMed ID: 31189352
[TBL] [Abstract][Full Text] [Related]
4. Enhanced CT-based texture analysis and radiomics score for differentiation of pleomorphic adenoma, basal cell adenoma, and Warthin tumor of the parotid gland.
Chen F; Ge Y; Li S; Liu M; Wu J; Liu Y
Dentomaxillofac Radiol; 2023 Jan; 52(2):20220009. PubMed ID: 36367128
[TBL] [Abstract][Full Text] [Related]
5. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
6. Epithelial salivary gland tumors: Utility of radiomics analysis based on diffusion-weighted imaging for differentiation of benign from malignant tumors.
Shao S; Mao N; Liu W; Cui J; Xue X; Cheng J; Zheng N; Wang B
J Xray Sci Technol; 2020; 28(4):799-808. PubMed ID: 32538891
[TBL] [Abstract][Full Text] [Related]
7. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
[TBL] [Abstract][Full Text] [Related]
8. Perfusion MR imaging detection of carcinoma arising from preexisting salivary gland pleomorphic adenoma by computer-assisted analysis of time-signal intensity maps.
Katayama I; Eida S; Fujita S; Hotokezaka Y; Sumi M; Nakamura T
PLoS One; 2017; 12(5):e0178002. PubMed ID: 28531213
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
10. Radiomics analysis of apparent diffusion coefficient in cervical cancer: A preliminary study on histological grade evaluation.
Liu Y; Zhang Y; Cheng R; Liu S; Qu F; Yin X; Wang Q; Xiao B; Ye Z
J Magn Reson Imaging; 2019 Jan; 49(1):280-290. PubMed ID: 29761595
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma ex pleomorphic adenoma of major salivary glands: CT and MR imaging findings.
Wang C; Yu Q; Li S; Sun J; Zhu L; Wang P
Dentomaxillofac Radiol; 2021 Oct; 50(7):20200485. PubMed ID: 34161740
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of qualitative and radiomics approach to parotid gland tumors: which is the added benefit of texture analysis?
Vernuccio F; Arnone F; Cannella R; Verro B; Comelli A; Agnello F; Stefano A; Gargano R; Rodolico V; Salvaggio G; Lagalla R; Midiri M; Lo Casto A
Br J Radiol; 2021 Dec; 94(1128):20210340. PubMed ID: 34591597
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MRI for differentiation between sialadenitis and pleomorphic adenoma.
Terra GT; Oliveira JX; Hernandez A; Lourenço SV; Arita ES; Cortes AR
Dentomaxillofac Radiol; 2017 Jan; 46(1):20160257. PubMed ID: 27845594
[TBL] [Abstract][Full Text] [Related]
14. Diffusion Weighted Imaging for Differentiating Benign from Malignant Orbital Tumors: Diagnostic Performance of the Apparent Diffusion Coefficient Based on Region of Interest Selection Method.
Xu XQ; Hu H; Su GY; Liu H; Shi HB; Wu FY
Korean J Radiol; 2016; 17(5):650-6. PubMed ID: 27587953
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of whole-tumor apparent diffusion coefficient map radiomics analysis in predicting early recurrence of solitary hepatocellular carcinoma ≤ 5 cm.
Wang L; Feng B; Wang S; Hu J; Liang M; Li D; Wang S; Ma X; Zhao X
Abdom Radiol (NY); 2022 Sep; 47(9):3290-3300. PubMed ID: 35776146
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features.
Kato H; Kawaguchi M; Ando T; Mizuta K; Aoki M; Matsuo M
Jpn J Radiol; 2018 Aug; 36(8):463-471. PubMed ID: 29845358
[TBL] [Abstract][Full Text] [Related]
18. Tumor blood flow and apparent diffusion coefficient histogram analysis for differentiating malignant salivary tumors from pleomorphic adenomas and Warthin's tumors.
Tanaka F; Umino M; Maeda M; Nakayama R; Inoue K; Kogue R; Obara M; Sakuma H
Sci Rep; 2022 Apr; 12(1):5947. PubMed ID: 35396374
[TBL] [Abstract][Full Text] [Related]
19. MR-Based Radiomics for Differential Diagnosis between Cystic Pituitary Adenoma and Rathke Cleft Cyst.
Wang Y; Chen S; Shi F; Cheng X; Xu Q; Li J; Luo S; Jiang P; Wei Y; Zhou C; Zheng L; Xia K; Lu G; Zhang Z
Comput Math Methods Med; 2021; 2021():6438861. PubMed ID: 34422095
[TBL] [Abstract][Full Text] [Related]
20. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
